Skip to main content
Elyse Lower, MD, Oncology, Cincinnati, OH

Elyse Ellen Lower MD


Professor, Internal Medicine, University of Cincinnati College of Medicine

Join to View Full Profile
  • 3199 Highland AveCincinnati, OH 45219

  • Phone+1 513-475-8500

  • Fax+1 513-584-4281

Dr. Lower is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Cincinnati Medical Center/College of Medicine
    University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 1984 - 1987
  • University of Cincinnati Medical Center/College of Medicine
    University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1981 - 1984
  • University of Cincinnati College of Medicine
    University of Cincinnati College of MedicineClass of 1981

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1983 - 2028
  • KY State Medical License
    KY State Medical License 1997 - 1999
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification IntelliDose, IntrinsiQ Specialty Solutions, Inc. FBO Healthtronics Information Technology Solutions Inc., 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017

Publications & Presentations

PubMed

Journal Articles

  • Biomarker discordance  
    Lower EE, Khan S, Biomarkers, 2013

Press Mentions

  • Methotrexate Proves Its Mettle as First-Line Therapy for Pulmonary Sarcoidosis
    Methotrexate Proves Its Mettle as First-Line Therapy for Pulmonary SarcoidosisMay 18th, 2025
  • Opinion: It's Time to Win the Fight Against Breast Cancer
    Opinion: It's Time to Win the Fight Against Breast CancerNovember 21st, 2022
  • Ohio Expanded Breast Cancer Screening Coverage. Will the Nation Follow?
    Ohio Expanded Breast Cancer Screening Coverage. Will the Nation Follow?June 30th, 2022

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: